Smooth Drug Development June 2025 News Release

Monthly News – June 2025

At Smooth Drug Development, we are excited to share the latest updates and achievements from June 2025:

New Projects

We are pleased to announce significant progress in our collaborations:

• Finalized contract for data management and biostatistics services for a BE trial of Nebivolol + Ramipril
• Secured drug supply contracts for multiple therapies including Ataluren, Ivacaftor combinations, Givinostat, Nivolumab and Pembrolizumab.
• Contract is signed for medical writing services for a Phase III Saroglitazar trial.

Clinical and Scientific Departments News:

Our clinical teams continue to deliver excellent results:

• Phase III Hematology Trial: Final patient completed participation 
• BE Hematology Trial: CSR accepted, site closed 
• Phase I Ophthalmology Trial: First patient randomized
• Women's Health Phase III: 12 site selection visits completed
• Melanoma/Glioma Study: All subjects completed participation

Business Development News:

Attended key industry events:

• CPHI China (24-26 June)
• BIO International Convention (Boston, USA)